Additional file 4 of Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer
收藏数据链接：
官方服务：
资源简介：
Additional file 4: Table S1. Table listing Ribociclib IC50 in each of the breast cancer cell lines. ER, AR and HER2 levels, as measured by RPPA, also included for reference.
提供机构：
figshare创建时间：
2020-08-15
